Articles

QPP is continuously involved in research, projects and developing information that can help people live well with HIV in Queensland. Read the latest updates here.

Home » Articles
  • Latest News

    Bictegravir – A new Integrase Inhibitor in the pipeline

    Bictegravir matches dolutegravir for first-line treatment in Phase 2 studies Paul Sax at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com Bictegravir, an investigational new integrase inhibitor, was highly potent, well tolerated and worked as well as dolutegravir (Tivicay – an existing …

  • Latest News

    Doravirine – a new NNRTI (Non-Nuke) option on the horizon

    Kathleen Squires at CROI 2017. Photo by Liz Highleyman, hivandhepatitis.com Doravirine, an investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) that reduced HIV viral load as well as boosted darunavir (a Protease Inhibitor) in a phase 3 clinical trial of people starting …

  • Latest News

    Aged Care Reforms – Increasing choice in home care

    As the HIV-positive population ages through the life-extending benefits of HIV treatments, age-related illness will (and already have) become an increasing concern, such as heart disease, diabetes, kidney disease, bone density loss, and some cancers. Alongside of this medication and treatment …

  • Latest News

    RAPID’s GeneXpert trial Update

    We are pleased to provide an update regarding the commencement of RAPID’s revolutionary STI testing project using GeneXpert technology, as announced by QPP in November 2016. The research pilot, involving partners from QPP, the University of Queensland School of Public Health, …

  • Latest News

    Peer Support Group Update

    QPP have been helping to coordinate monthly social events for People Living with HIV (PLHIV) across Queensland. We are expecting to extend social events to every region of the state in order to reach out to all people living with HIV. …

icon-angle icon-bars icon-times